US Patent 7799796 Diaminopyrimidines as P2X
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+150 characters)
Article
Patent abstract
Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the compounds being of formula (I):
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07799796 Diaminopyrimidines as P2X US Patent 7799796 Diaminopyrimidines as P2X
Infobox
Patent Number
0779979600
Patent Number
779979600
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
077997960
Date of Patent
September 21, 2010
0Patent Application Number
115098900
Date Filed
August 25, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
077997960
Date of Patent
September 21, 2010
0Patent Application Number
115098900
Date Filed
August 25, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07799796 Diaminopyrimidines as P2X
Infobox
Is a
Patent jurisdiction
Patent number
07799796
Date of patent
September 21, 2010
Patent application number
11509890
Date Filed
August 25, 2006
Patent primary examiner
Find more entities like US Patent 7799796 Diaminopyrimidines as P2X
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
